Venture capitalists are on a roll: in the past week two more firms confirmed the closing of significant new funds, to add to five others announced this year.
The UK’s system for pricing drugs is to move from one based on controlling profits to a value-based approach. The switch has implications for other countries in Europe.
One of Ireland’s best known scientific sons has been lured back from his post as Director General of the European Molecular Biology Organisation to take the helm at Science Foundation Ireland.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.